Because TSS-distal regulatory sites such as enhancers can be tumor-specific but still converge on common genes [38,39], we also determined if genes annotated to BRG1-dependent accessible sites (FDR < 0.05) show any commonalities. The gene discussed is SMARCA4; the disease is neoplasm.